BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 8514588)

  • 1. The contribution of clinical pharmacology to new drug approvals.
    Brown SA
    J Am Vet Med Assoc; 1993 May; 202(10):1700-2;discussion 1713-7. PubMed ID: 8514588
    [No Abstract]   [Full Text] [Related]  

  • 2. Professional responsibilities.
    Jenkins WL
    J Am Vet Med Assoc; 1993 May; 202(10):1742-3. PubMed ID: 8514601
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical pharmacology considerations regarding compounding.
    Powers TE
    J Am Vet Med Assoc; 1994 Jul; 205(2):221-3. PubMed ID: 7928581
    [No Abstract]   [Full Text] [Related]  

  • 4. An overview of current programs on drug development and regulation for small ruminants--pharmaceutical industry perspective.
    Terry M
    Vet Hum Toxicol; 1993; 35 Suppl 2():12-3. PubMed ID: 8236759
    [No Abstract]   [Full Text] [Related]  

  • 5. Professional drug labeling.
    Terry M
    J Am Vet Med Assoc; 1993 May; 202(10):1711-2;discussion 1713-7. PubMed ID: 8514591
    [No Abstract]   [Full Text] [Related]  

  • 6. Implications for the FDA/Center for Veterinary Medicine (CVM).
    Geyer RE
    J Am Vet Med Assoc; 1993 May; 202(10):1718-23. PubMed ID: 8514592
    [No Abstract]   [Full Text] [Related]  

  • 7. Increased approvals--myth or reality.
    Gingerich DA
    J Am Vet Med Assoc; 1993 May; 202(10):1703-7;discussion 1713-7. PubMed ID: 8514589
    [No Abstract]   [Full Text] [Related]  

  • 8. Scientific basis for nonapproved use of drugs in veterinary practice.
    Brumbaugh GW
    J Am Vet Med Assoc; 1993 May; 202(10):1693-6;discussion 1713-7. PubMed ID: 8514586
    [No Abstract]   [Full Text] [Related]  

  • 9. Extra-label drug use--pharmaceutical industry view.
    Welser JR
    J Am Vet Med Assoc; 1993 May; 202(10):1635-42;discussion 1654-8. PubMed ID: 8514571
    [No Abstract]   [Full Text] [Related]  

  • 10. Comments about vitamins, nutraceuticals, and dietary enzymes.
    Henderson TR
    J Am Vet Med Assoc; 1995 Jul; 207(1):31. PubMed ID: 7601686
    [No Abstract]   [Full Text] [Related]  

  • 11. Review of the first interactive workshop on professional flexible labeling. An Animal Health Institute perspective.
    Farho CJ
    J Am Vet Med Assoc; 1995 Oct; 207(7):869-71. PubMed ID: 7559007
    [No Abstract]   [Full Text] [Related]  

  • 12. The model veterinary drug code--what could it mean?
    McKean JD
    J Am Vet Med Assoc; 1988 Apr; 192(7):885-90. PubMed ID: 3366674
    [No Abstract]   [Full Text] [Related]  

  • 13. Review of the first interactive workshop on professional flexible labeling. The Center for Veterinary Medicine perspective.
    Sundlof SF
    J Am Vet Med Assoc; 1995 Oct; 207(7):867-8. PubMed ID: 7559006
    [No Abstract]   [Full Text] [Related]  

  • 14. Veterinary drug availability.
    Gloyd J
    J Am Vet Med Assoc; 1980 Apr; 176(7):611-4. PubMed ID: 7372533
    [No Abstract]   [Full Text] [Related]  

  • 15. Special pesticide formulations. Veterinarians must follow EPA rules.
    J Am Vet Med Assoc; 2004 Aug; 225(4):490-1. PubMed ID: 15344349
    [No Abstract]   [Full Text] [Related]  

  • 16. Flexible labeling, streamlined drug approval advocated at workshop.
    Raef TA
    J Am Vet Med Assoc; 1995 Jul; 207(1):7-9. PubMed ID: 7601697
    [No Abstract]   [Full Text] [Related]  

  • 17. American Academy of Veterinary Pharmacology and Therapeutics: perspectives on the utility of flexible drug labeling. An AAVPT perspective: Part II.
    Riviere JE
    J Am Vet Med Assoc; 1995 Oct; 207(7):876-8. PubMed ID: 7559010
    [No Abstract]   [Full Text] [Related]  

  • 18. Helpful tips for extralabel drug use: record keeping, record access, and product labels. The FDA-Center for Veterinary Medicine and the American Veterinary Medicine Association.
    J Am Vet Med Assoc; 1998 Mar; 212(5):666-7. PubMed ID: 9556375
    [No Abstract]   [Full Text] [Related]  

  • 19. Practitioners face conundrum with off-lable pesticide use. COBTA recommends regulatory discretion; prohibition remains.
    J Am Vet Med Assoc; 2004 Jul; 225(2):190-1. PubMed ID: 15323370
    [No Abstract]   [Full Text] [Related]  

  • 20. Extralabel drug use and compounding in veterinary medicine.
    Geyer RE
    Food Drug Law J; 1997; 52(3):291-5. PubMed ID: 10343027
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.